Provided by Tiger Trade Technology Pte. Ltd.

Repligen

165.86
+1.180.72%
Volume:274.58K
Turnover:45.56M
Market Cap:9.34B
PE:227.21
High:167.89
Open:166.72
Low:164.02
Close:164.68
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:0.66
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.42
PE(LYR):192.86

Loading ...

Repligen (RGEN) Stock Valuation After RBC Coverage Resumes And Q1 2026 Beat

Simply Wall St.
·
Jun 14

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC)

TIPRANKS
·
Jun 04

Repligen posts investor presentation outlining bioprocessing growth strategy, margin expansion path

Reuters
·
Jun 04

U.S. RESEARCH ROUNDUP-Aveanna Healthcare, Palo Alto, Ulta Beauty

Reuters
·
Jun 03

Repligen Coverage Assumed by Wolfe Research at Outperform

Dow Jones
·
Jun 02

Repligen assumed with an Outperform at Wolfe Research

TIPRANKS
·
Jun 02

Repligen CEO Loeillot presents at William Blair Growth Stock Conference

Reuters
·
May 22

Repligen publishes 2025 corporate sustainability report

Reuters
·
May 20

Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report

GlobeNewswire
·
May 20

Q/C Technologies Q1 net loss widens to USD 1.24 million

Reuters
·
May 16

Repligen Likely to Benefit From Diverse Growth Factors, RBC Says

MT Newswires Live
·
May 16

Repligen Price Target Announced at $160.00/Share by RBC Capital

Dow Jones
·
May 15

U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific

Reuters
·
May 15

Repligen Corp : RBC Resumes Coverage With Outperform Rating; Target Price $160

THOMSON REUTERS
·
May 15

Q/C Technologies director Chelsea Sierra Voss acquires 1,753 shares for $5,521.95

Reuters
·
May 15

Repligen resumed with an Outperform at RBC Capital

TIPRANKS
·
May 15

Alphabet Reports Stake In PayPay And CME Group, Dissolves In Dexcom

Reuters
·
May 08

Guggenheim Reaffirms Their Hold Rating on Repligen (RGEN)

TIPRANKS
·
May 08

Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference

GlobeNewswire
·
May 07

Repligen price target lowered to $165 from $180 at JPMorgan

TIPRANKS
·
May 07